Agents that activate CD47 and their use in the treatment of inflammation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11142548
APP PUB NO 20190225649A1
SERIAL NO

16300438

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are agents activating CD47 and their use in the treatment of inflammation, in particular non-resolving low grade inflammation, characterized by chronic MP infiltration, such as age-related macular degeneration. Also disclosed are pharmaceutical compositions, medicaments and kits including the agents.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SORBONNE UNIVERSITE; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Guillonneau, Xavier Boulogne Billancourt, FR 5 2
Housset, Michael Québec, CA 1 0
Karoyan, Philippe Courson-Monteloup, FR 9 2
Sahel, José-Alain Paris, FR 31 15
Sennlaub, Florian Paris, FR 16 26

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 12, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 12, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 12, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00